ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MPH Mereo Biopharma Group Plc

26.50
0.00 (0.00%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mereo Biopharma Group Plc LSE:MPH London Ordinary Share GB00BZ4G2K23 ORD GBP0.003 (REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 26.50 26.00 27.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Director Shareholding & Other

03/11/2003 5:57pm

UK Regulatory


RNS Number:6262R
Marchpole Holdings PLC
03 November 2003


FOR IMMEDIATE RELEASE 3 NOVEMBER 2003


                     Marchpole Holdings plc (the 'Company')

                            Disclosure of interests


The Company has been informed that, on 31 October 2003, Michael Morris,
director, disposed of 5,900,000 ordinary shares of 1 pence each in the Company
("Ordinary Shares"), representing 4.9 per cent. of the issued share capital, and
the US-based Robert Lomnitz 2003 Trust (the "Trust") acquired 5,900,000 Ordinary
Shares in the Company.

The shares were purchased by the exercise of an option entered into between
Michael Morris and the Trust on 8 July 2003 under the terms of which the initial
consideration for the shares was 5.25p per share with a deferred cash
consideration of up to 3.4p, the resulting maximum consideration payable being
8.65p per share.

Michael Morris is now interested in 30,230,048 Ordinary Shares representing 25.1
per cent. of the issued share capital and the Trust is interested in 11,910,000
Ordinary Shares (of which 6,010,000 are registered in the name of Paul Mourning,
the trustee of the Trust) representing 9.9 per cent. of the issued share capital
of the Company.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSDGMGMNFRGFZM

1 Year Mereo Biopharma Chart

1 Year Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

Your Recent History

Delayed Upgrade Clock